<DOC>
	<DOCNO>NCT00508885</DOCNO>
	<brief_summary>Hyperphosphatemia common peritoneal dialysis population . Current strategy insufficient optimize phosphorus control . Animal study show niacinamide , form vitamin B , reduce phosphate uptake rat small intestine . Our trial investigates use niacinamide , addition standard phosphorus lower strategy , reduce plasma phosphorus level peritoneal dialysis patient versus placebo .</brief_summary>
	<brief_title>The Effect Oral Niacinamide Plasma Phosphorus Levels Peritoneal Dialysis Patients</brief_title>
	<detailed_description>This prospective , randomize , double-blind , placebo-controlled 8-week clinical trial evaluate efficacy niacinamide versus placebo reduce plasma phosphorus level peritoneal dialysis patient . Patients stable regimen phosphate binder plasma phosphorus level &gt; 4.9 mg/dL eligible enrollment randomization . The study span 8 week active medication treatment . The primary end-point absolute change plasma phosphorus level . Sixteen patient ( 8 randomize treatment arm ) need detect 1.5 mg/dL difference assume standard deviation 1 power 80 % ( alpha 0.05 ) . Placebo package resemble study drug physical attribute . The start dose niacinamide 250 mg twice daily titrate 500 mg twice daily end week 2 final titration 750 mg twice daily end week 4 . Secondary end-points include absolute change calcium-phosphorus product , intact parathyroid hormone , hemoglobin , platelet count , total cholesterol , HDL cholesterol , percentage change plasma phosphorus .</detailed_description>
	<mesh_term>Hyperphosphatemia</mesh_term>
	<mesh_term>Niacinamide</mesh_term>
	<mesh_term>Niacin</mesh_term>
	<mesh_term>Nicotinic Acids</mesh_term>
	<criteria>Age &gt; 18 year Capable give informed consent Duration peritoneal dialysis &gt; 3 month Dose phosphate binder ( ) stable previous 2 week period Plasma phosphours &gt; 4.9 mg/dL base recent laboratory data within 1 month enrollment Pregnancy Known liver disease Active peptic ulcer disease Treatment carbamazepine Intolerance niacinamide niacin Current medication regimen include niacin niacinamide &gt; 100 mg daily Planned expect surgical procedure next 4 month Patients nurse home extend care facility administration study drug may appropriately give</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>July 2007</verification_date>
	<keyword>hyperphosphatemia</keyword>
	<keyword>niacinamide</keyword>
	<keyword>ESRD</keyword>
	<keyword>peritoneal dialysis</keyword>
	<keyword>renal osteodystrophy</keyword>
</DOC>